Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › Investigating the Influential Factors of Mild Water-Filtered Infrared-A Whole-Body Hyperthermia for Pain Relief in Fibromyalgia : A Mixed-Methods Approach Focusing on Predictors and Patient Perspectives

Publication

Investigating the Influential Factors of Mild Water-Filtered Infrared-A Whole-Body Hyperthermia for Pain Relief in Fibromyalgia : A Mixed-Methods Approach Focusing on Predictors and Patient Perspectives

Öznur, Özlem; Schlee, Christoph; Utz, Sandra; u. a. (2024): Investigating the Influential Factors of Mild Water-Filtered Infrared-A Whole-Body Hyperthermia for Pain Relief in Fibromyalgia : A Mixed-Methods Approach Focusing on Predictors and Patient Perspectives, in: Bamberg: Otto-Friedrich-Universität, S. 1–12.

Details

Faculty/Chair
Faculty/Professorship
Author
Öznur, Özlem
Langhorst, Jost
Publisher Information
Otto-Friedrich-Universität : Bamberg
Year of publication
2024
Source/Other editions
Biomedicines : open access journal, 11 (2023), 11, 2949, S. 1-12. - ISSN: 2227-9059
Year of first publication
2023
Language
English
Licence
URN
Abstract

Fibromyalgia syndrome (FMS) is a chronic condition characterized by chronic widespread pain, persistent fatigue, and disrupted sleep, significantly impacting well-being. Mild water-filtered infrared-A (wIRA) whole-body hyperthermia (WBH) is emerging as a promising pain management approach to FMS. Within the present randomized controlled trial (ClinicalTrials ID: NCT05135936), FMS patients underwent six sessions of mild wIRA-WBH over 3 weeks. Their pain levels were assessed at baseline and at week 12, while body core temperature and plateau phase duration were monitored during WBH. Qualitative interviews were conducted at week 12. Results from this mixed-methods study revealed that baseline pain intensity and plateau phase duration significantly predicted pain intensity at week 12. Thematic analysis of the interviews revealed diverse patient experiences with the treatment, with all patients reporting improvements in perceived pain and overall well-being. The onset and duration of pain relief varied among individuals. Overall, the findings suggest that the duration of the plateau phase may serve as an indicator for long-term pain reduction, although individual factors may influence treatment outcomes. Despite varying experiences, a prevailing trend of positive patient evaluations emerged. This study sheds light on the potential of wIRA-WBH as a therapeutic option for alleviating pain for and enhancing the well-being of FMS patients.

GND Keywords
Fibromyalgie
Ganzkörper-Hyperthermie
Schmerzlinderung
Keywords
fibromyalgia
whole-body hyperthermia
randomized controlled trial
integrative medicine
mixed methods
DDC Classification
610 Medicine & health
RVK Classification
YG 6915
Peer Reviewed
yes
International Distribution
yes
Open Access Journal
yes
Type
Article
URI
Activation date
2024-04-12

Permalink: https://fis.uni-bamberg.de/handle/uniba/94680 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-16

Restricted read-only access: login, editing and submission are temporarily disabled.